TRAP Phosphorylation Screening Using Oxidative Metal Ions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring TRAP phosphorylation in Staphylococcus aureus are time-consuming and costly, requiring radioactive isotopes, and the mechanism of TRAP phosphorylation is not fully understood, limiting the development of effective inhibitors.
Innovation Solution
A novel method for in vitro phosphorylation of TRAP using oxidative metal ions like iron, copper, and zinc, allowing for self-phosphorylation of TRAP without the RAP protein, and a method for screening inhibitors using a phosphorylation buffer, oxidizing ions, and ATP, which measures kinase activity to identify potential inhibitors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods for measuring TRAP phosphorylation are used, then phosphorylation can be measured, but the process is time-consuming and costly requiring radioactive isotopes
Solution Approach 1:
The invention extracts the essential components needed for TRAP phosphorylation (TRAP protein, ATP, and oxidative metal ions) from the complex in vivo system, creating a simplified in vitro assay that eliminates the need for radioactive isotopes and complex bacterial culture conditions while maintaining the ability to measure phosphorylation
Solution Approach 2:
The invention creates a simplified copy of the in vivo phosphorylation system by using purified TRAP protein and essential cofactors in a controlled in vitro environment, allowing measurement of phosphorylation without the complexity and hazards of radioactive labeling methods
2Measurement precision
If current methods for measuring TRAP phosphorylation are used, then phosphorylation can be measured, but the process is costly requiring radioactive isotopes
Solution Approach 1:
The invention replaces expensive radioactive isotopes with inexpensive, non-radioactive oxidative metal ions (such as Fe3+, Cu2+, Zn2+) that can be obtained from common salts, dramatically reducing the cost of the assay while maintaining measurement capability
Solution Approach 2:
The invention creates a cost-effective copy of the phosphorylation measurement system using readily available chemical reagents instead of expensive radioactive materials, making the assay accessible for routine screening and research applications
3Adaptability or versatility
If the mechanism of TRAP phosphorylation is not understood, then inhibitor development is limited, but understanding the mechanism requires complex in vivo studies
Solution Approach 1:
The invention segments the complex in vivo phosphorylation process into its essential components (TRAP protein, ATP, oxidative metal ions), allowing each component to be studied independently and facilitating the identification of mechanism-based inhibitors without requiring complex whole-cell systems
Solution Approach 2:
The invention introduces oxidative metal ions as intermediaries that mediate the phosphorylation reaction in a controllable manner, providing insight into the mechanism while offering potential targets for inhibitor development that would be difficult to identify in complex in vivo systems
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient and cost-effective in vitro phosphorylation of TRAP and rapid screening of inhibitors, potentially leading to the development of novel antibiotics effective against Staphylococcus aureus by identifying TRAP phosphorylation inhibitors.
Implementation Method 1
oxidative metal ions such as iron, copper and zinc
Implementation Method 2
oxidative metal ions like iron, copper, and zinc, allowing for self-phosphorylation of TRAP
Implementation Method 3
measures kinase activity to identify potential inhibitors
Data Source
AI summary
The present invention relates to a method for in vitro phosphorylation of TRAP derived from Staphylococcus aureus. In the present invention, the TRAP is first identified as a kinase that self-phosphorylates and is phosphorylated specifically in the presence of an oxidative metal ion such as iron, copper and zinc. Based upon this finding, a novel method for in vitro phosphorylation of purified TRAP is provided and also, a method for screening various chemicals and natural materials by using the above method is provided in order to select inhibitors against the TRAP phosphorylation. The inhibitors are expected to be applied for novel antibiotics of Staphylococcus aureus, because this TRAP phosphorylation is essential to infect Staphylococcus aureus. Therefore, the present invention can be widely used to develop novel drugs against Staphylococcus aureus and their resistant strains, in near future.